MedTrace Logo

The Circadian Rhythm of Copeptin

NCT02604875 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2016-08-15

No results posted yet for this study

Summary

The circadian rhythm of copeptin will be examined in healthy subjects.

Conditions

  • Circadian Rhythm
  • Copeptin Blood Levels

Interventions

OTHER

observation

blood sampling during 24 hours

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Mirjam Christ-Crain, MD, Prof. · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02604875 on ClinicalTrials.gov